Showing results (191-200 of 275) with videos related to

Sort By:
Pageof 28
Paediatric Respiratory Reviews|August 13, 2016
Risk factors for child pneumonia - focus on the Western Pacific RegionT K P Nguyen, T H Tran, C L Roberts, et al.
European Journal of Clinical Nutrition|September 17, 2015
Iron deficiency in early pregnancy using serum ferritin and soluble transferrin receptor concentrations are associated with pregnancy and birth outcomesA Z Khambalia, C E Collins, C L Roberts, et al.
Journal of the American College of Cardiology|June 1, 1990
Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditisS Tracy, V Wiegand, B McManus, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1970
Leukemia virus activation in chronic allogeneic diseaseM S Hirsch, P H Black, G S Tracy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 2008
Differential genotype dependent inhibition of CYP2C9 in humansVikas Kumar, Richard C Brundage, William S Oetting, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
Validation of incorporating flurbiprofen into the Pittsburgh cocktailNathalie K Zgheib, Reginald F Frye, Timothy S Tracy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 7, 2022
Pharmacokinetic Modeling of Warfarin І - Model-based Analysis of Warfarin Enantiomers with a Target Mediated Drug Disposition Model RevealsShen Cheng, Darcy R Flora, Allan E Rettie, et al.
Biochemical Pharmacology|October 25, 1996
Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9T S Tracy, C Marra, S A Wrighton, et al.
British Journal of Clinical Pharmacology|October 24, 2006
Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activityN K Zgheib, R F Frye, T S Tracy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 15, 2022
A Physiological-Based Pharmacokinetic Model Embedded with a Target-Mediated Drug Disposition Mechanism Can Characterize Single-Dose Warfarin Pharmacokinetic Profiles in Subjects with Various CYP2C9 Genotypes under Different CotreatmentsShen Cheng, Darcy R Flora, Allan E Rettie, et al.
Pageof 28